About the Company
Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health business segments. The Prescription Pharmaceuticals segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The Consumer Health segment offers branded and private-label animal health; and over-the-counter products. The company was founded in 1971 and is headquartered in Lake Forest, IL.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AKRX News
Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share. Fresenius announced a ...
Sandoz tries to overturn Duke's $39 million court victory
A drugmaker is trying to overturn a multimillion dollar court ruling involving Duke University and another pharmaceutical ...
Global Ophthalmic Eye Drops Industry is expected to reach a significant US$24.53 Billion by 2033, driven by a steady 4.2% CAGR. | FMI
The Global Ophthalmic Eye Drops Industry is poised to emerge as a beacon of growth, casting a radiant light on the expansive ...
NJ-based retailer among 50 biggest in America for 2024
Number of United States Stores in 2021: 7,019 US Retail Sales: $11.1 Billion Headquarters: Rochester, NY Number of United States Stores: 110 ...
DaVita to acquire Fresenius Medical Care entities for $300m
American healthcare company DaVita is set to expand its presence in the Latin American market with a $300m deal, which involves four separate acquisitions of Fresenius Medical Care entities. The U.S.
Loading the latest forecasts...